Literature DB >> 21812940

Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials.

E A Diakos1, I D Gallos, S El-Shunnar, M Clarke, R Kazi, H Mehanna.   

Abstract

BACKGROUND: Tonsillectomy is one of the most common surgical procedures, but there is debate whether systemic steroids should be used to reduce pain and post-operative complications. OBJECTIVE OF REVIEW: To determine whether peri-operative steroids reduce post-tonsillectomy pain and complications in adults. TYPE OF REVIEW: Systematic review and meta-analysis of randomised controlled trials. SEARCH STRATEGY: We searched MEDLINE (1950-2010), EMBASE (1980-2010), CINAHL (1981-2010), Web of Science, ProQuest, metaRegister, Conference Proceedings Citation Index, the Cochrane Library and reference lists of relevant studies. EVALUATION
METHOD: Two reviewers independently selected trials and extracted data on their quality, characteristics and results. Trials included adults (age >16 years) undergoing elective tonsillectomy where peri-operative steroids were used, and the results were compared with control or placebo.
RESULTS: There were seven randomised controlled trials (580 patients) reporting post-operative pain. Meta-analysis demonstrates that dexamethasone in adults reduces the pain level experienced in the first post-tonsillectomy day [standard mean difference (SMD): -0.63, 95% CI: -1.13 to -0.12] with significant heterogeneity (I(2) = 84%, P < 0.00001). Sub-group analysis to explore heterogeneity demonstrated this reduction in pain was mostly with high total dose steroids (total >10 mg over first 24 h post-operatively; SMD: -1.48, 95% CI: -2.17 to -0.79, P < 0.00001), especially when given both intra-operatively and post-operatively. There was no significant effect with low doses (SMD: -0.12, 95% CI: -0.36 to 0.13, P = 0.35). There were three trials (231 patients) that reported post-operative nausea and vomiting, three other trials (270 patients) reporting on bleeding and three trials (401 patients) reporting other complications (infections and odynophagia). There was a significant reduction in post-operative nausea and vomiting (RR: 0.53, 95% CI: 0.36 to 0.80, P = 0.002, I(2) = 26%) and bleeding (RR: 0.45, 95% CI: 0.25 to 0.80, P = 0.007, I(2) = 0%), but the reduction in the other complications did not reach statistical significance (RR: 0.69, 95% CI: 0.48 to 1.01, P = 0.06, I(2) = 0%). Pooling of these complications (post-operative nausea and vomiting, bleeding, infections and odynophagia) shows that in six trials (501 patients), the use of dexamethasone significantly reduced post-operative complications following tonsillectomy in adults (RR: 0.59, 95% CI: 0.49 to 0.71, P < 0.00001, I(2) = 0%), when compared with placebo or control.
CONCLUSIONS: Dexamethasone reduces pain, post-operative nausea and vomiting, bleeding and overall post-operative complications in adults undergoing tonsillectomy. However, the effect of the dose of dexamethasone on post-operative pain and whether dexamethasone reduces bleeding require further research.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812940     DOI: 10.1111/j.1749-4486.2011.02373.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  10 in total

1.  The effects of levobupivacaine infiltration on post-tonsillectomy pain relief in adults: a single-blinded, randomized, and controlled clinical study.

Authors:  Fikret Kasapoglu; Uygar Levent Demir; Fatma Nur Kaya; Yaser Sait Cetin; Belgin Yavascaoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-30       Impact factor: 2.503

Review 2.  [Perioperative dexamethasone].

Authors:  B Sinner
Journal:  Anaesthesist       Date:  2019-10       Impact factor: 1.041

3.  Postoperative leukocyte changes in facial fracture patients: a randomized prospective study with short-term dexamethasone.

Authors:  Johanna Snäll; Jyrki Törnwall; Anna Liisa Suominen; Hanna Thorén
Journal:  Oral Maxillofac Surg       Date:  2017-04-06

4.  The efficacy of single-dose postoperative intravenous dexamethasone for pain relief after endoscopic submucosal dissection for gastric neoplasm.

Authors:  Hye Won Lee; Hyuk Lee; Hyunsoo Chung; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Young Chan Lee; Jung Hwa Hong; Dong Wook Kim
Journal:  Surg Endosc       Date:  2014-02-26       Impact factor: 4.584

5.  In Ear Surgeries Intravenous Dexamethasone Preoperatively Decreases Post Operative Sore Throat After Endotracheal Intubation in Adult Patients: A Prospective Randomized Control Study.

Authors:  Gurchand Singh; Anisha Puri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-02

6.  Comparison of Fentanyl plus different doses of dexamethasone with Fentanyl alone on postoperative pain, nausea, and vomiting after lower extremity orthopedic surgery.

Authors:  Ghodrat Akhavan Akbari; Ali Mohammadian Erdi; Farzad Nabipour Asri
Journal:  Eur J Transl Myol       Date:  2022-04-29

Review 7.  Malpractice claims and unintentional outcome of tonsil surgery and other standard procedures in otorhinolaryngology.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

8.  Dexamethasone and post-adenotonsillectomy pain in children: Double-blind, randomized controlled trial.

Authors:  Young Kang; Eu Jeong Ku; Il Gu Jung; Min Hyuck Kang; Young-Seok Choi; Hahn Jin Jung
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

Review 9.  Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era.

Authors:  Laura Kalfeist; Loïck Galland; Fanny Ledys; François Ghiringhelli; Emeric Limagne; Sylvain Ladoire
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

10.  A Comparative Randomized Trial on the Optimal Timing of Dexamethasone for Pain Relief after Endoscopic Submucosal Dissection for Early Gastric Neoplasm.

Authors:  Jeung Hui Pyo; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  Gut Liver       Date:  2016-07-15       Impact factor: 4.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.